1. Actonel [Prescribing Information] Rockaway, NJ: Warner Chilcott, LLC; April 2015.
2. Atelvia [Prescribing Information] Rockaway, NJ: Warner Chilcott, LLC; April 2015.
3. Fosamax Plus D [Prescribing Information] Whitehouse Station, NJ: Merck & Co., Inc; November 2015.
4. Binosto [Prescribing Information] San Antonio, TX: Mission Pharmacal Company; February 2015.
5. National Osteoporosis Foundation-The Clinicians Guide to Prevention and Treatment of Osteoporosis. Available at: http://nof.org/files/nof/public/content/file/2791/upload/919.pdf. Accessed June 17, 2015.
6. The North American Menopause Society. Management of postmenopausal osteoporosis: 2010 position statement of the North American Menopause Society. Menopause 2010;17(1):22-54.
7. Watts NB, Bilezikian JP, Camacho PM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 2010;16(Suppl 3):1-37.
8. Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 2010;62(11):1515-1526.
9. Risedronate. American Hospital Formulary Service Drug Information. Available at: http://www.medicinescomplete.com/mc/ahfs.current/. Accessed February 27, 2016.
10. Alendronate. American Hospital Formulary Service Drug Information. Available at: http://www.medicinescomplete.com/mc/ahfs.current/. Accessed February 27, 2016.
11. MicromedexR Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Healthcare. Updated periodically. Accessed February 27, 2016.
12. Clinical Pharmacology Web site. Available at http://cpip.gsm.com/. Accessed February 25, 2016.